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THE stimulating effect of a variety of drugs and carcinogens on ascorbic acid
synthesis and excretion in the rat was reviewed by Burns and Shore (1961) and
by Conney, Bray, Evans and Burns (1961). The enhanced urinary excretion of
ascorbic acid was attributed to modified metabolism of glucose (Burns, Evans
and Trousof, 1957) or galactose (Evans, Conney, Trousof and Burns, 1960) via
the glucuronic acid pathway (Burns et al., 1960). Single doses of the carcinogenic
hydrocarbons 1,2: 5, 6-dibenzanthracene (Allen and Boyland, 1957; Boyland
and Grover, 1961) and 3-methylcholanthrene (Conney and Burns, 1959) increase
the urinary ascorbic acid for more than twenty days after an initial three-day
latent period. In contrast, barbitone causes an immediate increase in ascorbic
acid excretion which is of short duration. Touster, Hester and Siler (1960) and
Touster and Hollmann (1961) showed that the enhancement of ascorbic acid
excretion due to either barbitone or 3-methylcholanthrene could be blocked in
the rat by DL-ethionine. Salomon and Stubbs (1961) showed that normal and
chloretone-induced ascorbic acid excretion was influenced by the hormone status
of the rats.
In view of the inhibitory effect of DL-ethionine on the stimulation of ascorbic
acid excretion, the effect of a low protein diet on the response to barbitone and 3-
methylcholanthrene was tested. Attempts were made to determine to what
extent the barbitone and 3-methylcholanthrene response was under hormone
control. The present work describes the effect of (a) DL-ethionine and low
protein diet; (b) inhibitors of the adrenal cortex, 2-methyl-1,2-bis-(3-pyridyl)-
I-propanone (SU4885) and 2-o-chlorophenyl-2-p-chlorophenyl-1,1-dichloroethane
(o-p'-DDD); (c) adrenalectomy, thyroidectomy and partial hepatectomy, on the
enhancement of urinary ascorbic acid by 3-methylcholanthrene and barbitone.
ANIMALS AND METHODS
Male albino rats of the Chester Beatty Strain weighing 250/350 g. were main-
tained on a 20 per cent protein diet and water in individual all-glass metabolism
cases. Urine was collected daily into 10 ml. of 12 per cent w/v metaphosphoric
acid solution, made up to standard volume and assayed for ascorbic acid content
by the 2,6-dichlorophenol-indophenol titration method ofHarris and Olliver (1942)
and in some cases by the method of Roe and Kuether (1943). A base line was
established for at least three consecutive days. Chemical or nutritional pre-
treatment (if any) was then instituted for four days so that the test animals were
equilibrated before 3-methylcholanthrene (50 mg./kg./i.p.) or barbitone (50 mg./E. BOYLAN;D ANID W. R. JONDORF
rat i.p. on three successive days) was administered. Rats were given four or
five days to recover from any surgical pretreatment before the treatment with
3-methylcholanthrene or barbitone.
Chemicals were given by intraperitoneal injection either as aqueous solutions
(DL-ethionine, sodium barbitone), buffered solutions (SU4885 at pH 7-4), or in
arachis oil (o-p'-DDD solution, 3-methylcholanthrene suspension). Thyroxine was
administered subcutaneously. All experiments were carried out at least in
duplicate.
RESULTS
(a).-A single injection o4f 3-methylcholanthrene (50 mg./kg. i.p.) caused a
substantial increase in ascorbic acid excretion which persisted for some weeks
after a lag of two to three days (Fig. 1, curve B). Injection of barbitone (50
mg./rat i.p.) caused an immediate increase in ascorbic acid excretion which lasted
for some days (Fig. 1, curve E). Rats given DL-ethionine (100 mg./kg./day i.p.)
or maintained on 5 per cent protein diet for four days preceding the administration
of 3-methylcholanthrene or barbitone and then continuously until the end of the
experiment did not show any increase in ascorbic acid output beyond the normal
range (Fig. 1, curve A). The animals so treated had a lower growth rate (ca.
3 g./rat/day) than the control animals (ca. 8 g./rat/day).
(b).-Pretreatment with compound SU4885 (100 mg./kg./day i.p.), known to
reduce adrenocortical function (Brown, 1960), four days before the administra-
tion of 3-methylcholanthrene, delayed and diminished the response to 3-methyl-
cholanthrene so that the daily output of urinary ascorbic acid was according to
pattern D (Fig. 1); control values were also lowered (daily output 0-5-1-0 mg.
ascorbic acid). The barbitone induced increase of ascorbic acid output is com-
pletely blocked by SU4885 (Table I).
TABLE I.-Urinary Ascorbic Acid Excretion Patterns in Rats, as Illustrated in
Fig. 1, Under Different Conditions
Treatment
Dose 3-MC Barbitone
Pretreatment (mg./kg-) None (50mg./kg.i.p.) (50mg./rati.p)
None . . A (8) B (6) E (2)
DL-ethionine . 100 . A (2) A (4) A (2)
5% protein diet A (2) A (2) A (2)
SU4885 . . 100 . A (3) D (4) A (2)
o-p'-DDD . . 20 . 0(4) C (4)
Adrenalectomy . A (2) D (2) A (4) E (2)
Thyroidectomy . A (2) A (3) A (2)
Partial hepatectomy . . A (4) B (3)
Figures in parentheses indicate number of animals used.
o-p'-DDD (20 mg./kg./day i.p.) which is an adrenal antagonist in some species
(Brown, 1960) but apparently not in the rat (Hertz, 1961 personal communication),
enhanced the urinary output immediately; the effect summated with that of
3-methylcholanthrene to give excretions of 20 mg. per day (Fig. 1, curve C).
A single dose of o-p'-DDD (100 mg./kg. i.p.) stimulated the ascorbic acid ex-
cretion more than did 3-methylcholanthrene. The effect was immediate and
also of greater magnitude and duration. A daily output of more than 20 mg.
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FIG. 1.-Urinary ascorbic acid excretion patterns in rats measured daily by titration with
2,6-dichlorophenol-indophenol.
A [0-0] control;
B [0-0] following an injection of 3-MC ($0 mg./kg. i.p.) on day 7;
C [U-*] following daily injections of o-p'-DDD (20 mg./kg. i.p.) from day 3 onwards
and a single injection of 3-MC (50 mg./kg. i.p.) on day 7;
D [E-E] following daily injections of SU4885 (100 mg./kg. i.p.) from day 3 onwards
and a single injection of 3-MC (50 mg./kg. i.p.) on day 7;
E [A-A] following three successive injections of barbitone (50 mg./rat i.p.) on days
7, 8 and 9.
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ascorbic acid was sustained for more than twenty days. The excretion there-
after declined but was still raised after thirty days.
(c).-Burns, et at. (1957) had found that adrenalectomy did not appear to
affect the excretion ofascorbic acid in rats challenged withbarbitone or chloretone.
In the present experiments the ascorbic acid output in adrenalectomised rats
was the same as in intact rats when the animals were given three successive doses
of barbitone (Table I). However, 3-methyleholanthrene increased ascorbic
acid excretion in only two out of six adrenalectomised rats (response similar to
D in Fig. 1).
Thyroidectomised animals did not show any increase in urinary ascorbic
acid output when 3-methylcholanthrene or barbitone were administered in the
usual doses. Sham-operated animals, however, reacted like normal rats with
excretion patterns B and E respectively. Thyroidectomised animals supplemented
with thyroxine (0.03 mg./rat/day s.c.) for three days still behaved as thyroidecto-
mised rats in their response to 3-methylcholanthrene and barbitone.
Partial hepatectomy was investigated in order to determine ifliver regeneration
caused increased synthesis of specific proteins necessary for production of inter-
mediates in the glucuronide pathway. Partial hepatectomy itself did not change
the rate of ascorbic acid output. The response of hepatectomised rats given 3-
methylcholanthrene was similar to that of intact rats although the response was
delayed, the peak being reached about the eleventh day after injection.
(d).-Slonaker and August rats of the same age as the Chester Beatty rats
gave similar response to 3-methylcholanthrene in spite of the fact that they had
a much smaller growth rate (2 g./day) and had attained weights ofonly 100-120 g.
at the time of experimentation.
DISCUSSION
The increase in ascorbic acid synthesis and excretion induced by carcinogens
and other compounds appears to be induced by similar factors to those which
increase the liver microsomal enzymes responsible for metabolising foreign
compounds (Conney, Miller and Miller, 1956; Conney and Burns, 1959). Both
types of effect must involve synthesis of enzymes which carry out the chemical
processes involved.
The finding that DL-ethionine administration or low protein diet inhibits the
response to 3-methylcholanthrene or barbitone as measured by urinary ascorbic
acid output in rats, is in agreement with the concept of induced protein synthesis.
However, protein synthesis per se does not enhance the urinary ascorbic acid
output as was seen with rats that had been partially hepatectomised. Evidently
the synthesis of specific liver proteins is involved in the increase of ascorbic acid
excretion.
SU4885, whichspecifically inhibits 11-hydroxylation inC1921 steriods (Jenkins,
Meakin, Nelson and Thorn, 1958) depressed ascorbic acid output of control and
3-methylcholanthrene stimulated rats, the effect of some 11-desoxysteroids should
be investigated in connection with the phenomenon.
A surprising finding was the response elicited in rats with the other anti-
adrenal compound tested, o-p'-DDD. o-p'-DDD was found to be a much more
potent and long lasting stimulator ofascorbic acid output in the ratthan 3-methyl-
cholanthrene.
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SUMMARY
1. The 3-methylcholanthrene and barbitone induced increases in ascorbic
acid excretion in rats are dependent on dietary and hormonal factors but not on
overall growth rate.
2. The induction ofincreased ascorbic acid output is prevented by administra-
tion of DL-ethionine or by a low protein diet.
3. Adrenalectomy sometimes neutralises the effect of 3-methylcholanthrene
on ascorbic acid excretion but not that of barbitone.
4. The adrenal antagonist SU4885 suppresses the increase of ascorbic acid
output induced by 3-methylcholanthrene or barbitone.
5. o-p'-DDD which is an anti-adrenal compound in other species enhances
the induction brought about by 3-methylcholanthrene and is itself a powerful
and long acting stimulator of ascorbic acid output.
6. Thyroidectomy prevents the induction of increased ascorbic acid output
with 3-methylcholanthrene or barbitone.
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